The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jan. 29, 2013
Filed:
Mar. 15, 2011
Naing Aay, San Mateo, CA (US);
Neel Kumar Anand, Burlingame, CA (US);
Charles M. Blazey, San Francisco, CA (US);
Owen Joseph Bowles, Pacifica, CA (US);
Joerg Bussenius, Foster City, CA (US);
Simona Costanzo, Los Altos, CA (US);
Jeffry Kimo Curtis, San Anselmo, CA (US);
Steven Charles Defina, Burlingame, CA (US);
Larisa Dubenko, San Francisco, CA (US);
Anagha Abhijit Joshi, Fremont, CA (US);
Abigail R. Kennedy, Oakland, CA (US);
Angie Inyoung Kim, San Mateo, CA (US);
Elena S. Koltun, Foster City, CA (US);
Jean-claire Limun Manalo, Daly City, CA (US);
Csaba J. Peto, Alameda, CA (US);
Kenneth D. Rice, San Rafael, CA (US);
Tsze H. Tsang, El Cerrito, CA (US);
Naing Aay, San Mateo, CA (US);
Neel Kumar Anand, Burlingame, CA (US);
Charles M. Blazey, San Francisco, CA (US);
Owen Joseph Bowles, Pacifica, CA (US);
Joerg Bussenius, Foster City, CA (US);
Simona Costanzo, Los Altos, CA (US);
Jeffry Kimo Curtis, San Anselmo, CA (US);
Steven Charles DeFina, Burlingame, CA (US);
Larisa Dubenko, San Francisco, CA (US);
Anagha Abhijit Joshi, Fremont, CA (US);
Abigail R. Kennedy, Oakland, CA (US);
Angie Inyoung Kim, San Mateo, CA (US);
Elena S. Koltun, Foster City, CA (US);
Jean-Claire Limun Manalo, Daly City, CA (US);
Csaba J. Peto, Alameda, CA (US);
Kenneth D. Rice, San Rafael, CA (US);
Tsze H. Tsang, El Cerrito, CA (US);
Exelixis, Inc., San Francisco, CA (US);
Abstract
Disclosed are compounds of Formula (I) and pharmaceutically acceptable salts and solvates thereof. Such compounds are MEK inhibitors and are useful in the treatment of proliferative diseases, such as cancer. Also disclosed are pharmaceutical compositions containing such compounds as well as methods of using the compounds and compositions of the invention in the treatment of cancer.